RIGI and ovarian carcinoma: In a retrospective study with 141 cases of ovarian cancer, RIG-I was overexpressed (compared to healthy ovarian tissue) and a high expression correlated with higher tumor grade as well as to poorer outcome (Wolf et al. 2020).